Eupraxia Pharmaceuticals Stock Analysis
| EPRX Stock | CAD 6.87 0.14 2.00% |
Eupraxia Pharmaceuticals is fairly valued with Real Value of 6.69 and Hype Value of 6.87. The main objective of Eupraxia Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Eupraxia Pharmaceuticals is worth, separate from its market price. There are two main types of Eupraxia Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Eupraxia Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Eupraxia Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Eupraxia Pharmaceuticals stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Eupraxia Pharmaceuticals is usually not traded on Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day. Eupraxia Stock trading window is adjusted to America/Toronto timezone.
Eupraxia |
Eupraxia Stock Analysis Notes
About 19.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.04. Eupraxia Pharmaceuticals had not issued any dividends in recent years. Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. EUPRAXIA PHARMACEUTICALS operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 19 people. To learn more about Eupraxia Pharmaceuticals call MD FRCPC at 250-590-3968 or check out https://www.eupraxiapharma.com.Eupraxia Pharmaceuticals Investment Alerts
| Eupraxia Pharmaceuticals had very high historical volatility over the last 90 days | |
| Net Loss for the year was (25.74 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eupraxia Pharmaceuticals has accumulated about 35.46 M in cash with (29.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. | |
| Roughly 19.0% of the company shares are held by company insiders |
Eupraxia Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 251.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eupraxia Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Eupraxia Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 23rd of July, Eupraxia Pharmaceuticals shows the Downside Deviation of 2.33, coefficient of variation of 765.76, and Mean Deviation of 2.01. Eupraxia Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Eupraxia Pharmaceuticals Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Simple Moving Average indicator is calculated by adding the closing price of Eupraxia Pharmaceuticals for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Eupraxia Pharmaceuticals short-term fluctuations and highlight longer-term trends or cycles.
Eupraxia Pharmaceuticals Outstanding Bonds
Eupraxia Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eupraxia Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eupraxia bonds can be classified according to their maturity, which is the date when Eupraxia Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Eupraxia Pharmaceuticals Predictive Daily Indicators
Eupraxia Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eupraxia Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Eupraxia Pharmaceuticals Forecast Models
Eupraxia Pharmaceuticals' time-series forecasting models are one of many Eupraxia Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eupraxia Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Eupraxia Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Eupraxia Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eupraxia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eupraxia Pharmaceuticals. By using and applying Eupraxia Stock analysis, traders can create a robust methodology for identifying Eupraxia entry and exit points for their positions.
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. EUPRAXIA PHARMACEUTICALS operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 19 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Eupraxia Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Other Information on Investing in Eupraxia Stock
Eupraxia Pharmaceuticals financial ratios help investors to determine whether Eupraxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eupraxia with respect to the benefits of owning Eupraxia Pharmaceuticals security.